Tiagabine Hydrochloride
- Product NDC
- 16714-151
- 11-digit product format
- 167140151
- Labeler code
- 16714
- Product ID
- 16714-151_03a5672d-d01c-495c-91d9-d1f4e8426093
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tiagabine Hydrochloride
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Northstar Rx LLC
- Application
- ANDA214816
- Marketing category
- ANDA
- Marketing start
- 2021-11-24
- Marketing end
- 0000-00-00
- Substance
- TIAGABINE HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16714-151-01 | 16714015101 | 30 TABLET in 1 BOTTLE (16714-151-01) | 30 tablet | 2021-11-24 | 0000-00-00 | No | No | Current |